Jean Coutu sales up but profit weighed by generic prices - BNN Bloomberg

Jean Coutu sales up but profit weighed by generic prices - BNN Bloomberg

4.8
(176)
Write Review
More
$ 34.00
Add to Cart
In stock
Description

The Quebec-based pharmacy company had $47.8 million or 26 cents per share of net income in its fourth quarter, ended March 4 — down seven per cent from the comparable period last year.

BNN's Daily Chase: NHL playoffs boost Canada's economy; Clark's government toppled in B.C. - BNN Bloomberg

Can Prices Really Fall?

Canada Nutraceuticals Market - Growth, Trends and Forecasts (2019 - 2024), PDF, Probiotic

When Profitable Sales Growth Leads To Bankruptcy !

Savedrecs, PDF, Maternal Death

Jean Coutu profits up despite generics

Canada Nutraceuticals Market - Growth, Trends and Forecasts (2019 - 2024), PDF, Probiotic

Inflation Story Spun by CEOs Is Debunked by Fat Profit Margins - Bloomberg

Novo Nordisk Sales Soar, Fortifying Grip on Obesity Drug Market - Bloomberg

How Not to Negotiate a $6.1 Billion Deal - Bloomberg

How Not to Negotiate a $6.1 Billion Deal - Bloomberg

Jean Coutu sales up but profit weighed by generic prices - BNN